AMETEK Q3 sales rise 11%, beat expectations

Reuters
Oct 30, 2025
AMETEK Q3 sales rise 11%, beat expectations

Overview

  • AMETEK Q3 sales rise 11% yr/yr to $1.89 bln, beating analyst expectations

  • Adjusted EPS for Q3 increases 14% yr/yr, beating consensus

  • Company raises full-year adjusted EPS guidance to $7.32-$7.37

Outlook

  • AMETEK raises full-year adjusted EPS guidance to $7.32-$7.37

  • Company expects Q4 sales to rise 10% year-over-year

  • Company anticipates Q4 adjusted EPS of $1.90-$1.95

Result Drivers

  • EIG SALES GROWTH - EIG sales increased 10% yr/yr, contributing to margin expansion

  • EMG SALES GROWTH - EMG sales rose 13% yr/yr, leading to record operating income and margin expansion

  • FARO INTEGRATION - Progress in FARO Technologies integration seen as positive for future growth

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Beat

$1.89 bln

$1.82 bln (11 Analysts)

Q3 Adjusted EPS

Beat

$1.89

$1.76 (14 Analysts)

Q3 EPS

$1.60

Q3 Net Income

$371.41 mln

Q3 Basic EPS

$1.61

Q3 Operating income

$488.38 mln

Q3 Pretax Profit

$447.96 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 8 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the electrical components & equipment peer group is "buy"

  • Wall Street's median 12-month price target for AMETEK Inc is $211.00, about 12.7% above its October 29 closing price of $184.19

  • The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 25 three months ago

Press Release: ID:nPn3fkDr7a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10